These data suggest that there is an interaction between ceramide-producing enzymes and SphKs and that SphK1 may increase while SphK2 decreases the ratio of ceramide/S1P, leading to differential regulation of oxidant-induced kidney injury. Here, SPHK1 is linked to medical procedure.